"Hunterdon Cardiovascular Associates is committed to ensuring that you get optimal care in all of your medical needs. To help ensure that you get superior outcomes, we advise you to inform all of your doctors that we are your cardiology group and can help in managing any cardiovascular related issues."

During the past decade, Hunterdon Cardiovascular Associates conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hunterdon Cardiovascular Associates" #1 sponsor was "Abbott Medical Devices" with 1 trials, followed by "Abbott Nutrition" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "C. R. Bard" with 1 trials sponsored and "Terumo Medical Corporation" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hunterdon Cardiovascular Associates" #1 collaborator was "Beth Israel Deaconess Medical Center" with 1 trials as a collaborator, "ClinLogix. LLC" with 1 trials as a collaborator, "Massachusetts General Hospital" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Hunterdon Cardiovascular Associates" are "Atrial Fibrillation" (1 trials), "Femoral Artery Occlusion" (1 trials), "Femoral Artery Stenosis" (1 trials), "Hospitalized Elderly" (1 trials) and "Optim Lead Insulation Related Adverse Events" (1 trials). Many other conditions were trialed in "Hunterdon Cardiovascular Associates" in a lesser frequency.

Most popular intervention types in "Hunterdon Cardiovascular Associates" are "Device" (2 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Acetylsalicylic acid" (1 trials), "Apixaban" (1 trials), "Lutonix DCB" (1 trials), "Misago™ Self-Expanding Stent System" (1 trials) and "Ready to Drink Flavored Beverage" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hunterdon Cardiovascular Associates" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Hunterdon Cardiovascular Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Hunterdon Cardiovascular Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hunterdon Cardiovascular Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".